UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (252) 252
life sciences & biomedicine (242) 242
humans (216) 216
female (140) 140
male (139) 139
middle aged (127) 127
experiment (112) 112
gastroenterology & hepatology (106) 106
particle physics (106) 106
physics - high energy physics - experiment (99) 99
high energy physics - experiment (98) 98
physics (98) 98
surgery (92) 92
aged (90) 90
adult (89) 89
liver transplantation (78) 78
liver cancer (74) 74
hepatocellular carcinoma (72) 72
oncology (70) 70
liver neoplasms - surgery (68) 68
high energy physics (65) 65
liver (61) 61
transplantation (61) 61
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (59) 59
abridged index medicus (57) 57
carcinoma, hepatocellular - surgery (48) 48
treatment outcome (48) 48
liver neoplasms - pathology (46) 46
phenomenology (43) 43
liver neoplasms - mortality (39) 39
tumors (39) 39
carcinoma, hepatocellular - pathology (38) 38
hepatoma (38) 38
prognosis (37) 37
gastroenterology and hepatology (36) 36
cancer (35) 35
analysis (31) 31
carcinoma, hepatocellular - mortality (31) 31
liver cirrhosis (31) 31
patients (31) 31
retrospective studies (29) 29
liver neoplasms - therapy (27) 27
risk factors (27) 27
survival (27) 27
adolescent (26) 26
settore med/18 - chirurgia generale (26) 26
aged, 80 and over (25) 25
carcinoma, hepatocellular - therapy (25) 25
follow-up studies (25) 25
liver neoplasms - genetics (25) 25
nuclear experiment (25) 25
cern lhc coll (24) 24
carcinoma, hepatocellular - genetics (23) 23
experimental results (23) 23
transplants & implants (23) 23
animals (21) 21
patient selection (21) 21
survival analysis (21) 21
young adult (21) 21
care and treatment (20) 20
medical prognosis (20) 20
neoplasm staging (19) 19
prospective studies (19) 19
time factors (19) 19
hepatology (18) 18
kaplan-meier estimate (18) 18
liver neoplasms - secondary (18) 18
research (18) 18
scattering [p p] (18) 18
survival rate (18) 18
child (17) 17
metastasis (17) 17
syngeneic grafts (17) 17
allografts (16) 16
health aspects (16) 16
liver diseases (16) 16
liver neoplasms - drug therapy (16) 16
liver transplantation - adverse effects (16) 16
disease-free survival (15) 15
immunohistochemistry (15) 15
italy (15) 15
liver neoplasms - diagnosis (15) 15
mortality (15) 15
proportional hazards models (15) 15
transplantation of organs, tissues, etc (15) 15
8000 gev-cms (14) 14
carcinoma, hepatocellular - drug therapy (14) 14
chemotherapy (14) 14
hepatectomy (14) 14
immunology (14) 14
colliding beams [p p] (13) 13
liver neoplasms - complications (13) 13
mutation (13) 13
neuroendocrine tumors (13) 13
niacinamide - analogs & derivatives (13) 13
risk assessment (13) 13
antineoplastic agents (12) 12
disease progression (12) 12
life sciences (12) 12
liver cirrhosis - complications (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 05/2014, Volume 63, Issue 5, pp. 844 - 855
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1344 - 1354
Summary Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 07/2018, Volume 69, Issue 1, pp. 182 - 236
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90%... 
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver cancer | Hepatocellular carcinoma | Clinical medicine | Decision making
Journal Article